降纤酶联合丹参酮ⅡA磺酸钠对急性脑梗死患者的疗效和血液流变学的影响
急性脑梗死；降纤酶；丹参酮ⅡA磺酸钠；临床疗效,,],急性脑梗死；降纤酶；丹参酮ⅡA磺酸钠；临床疗效,1资料与方法,2结果,3讨论,[参考文献]
[摘要] 目的 评价降纤酶联合丹参酮ⅡA磺酸钠注射液(STS)治疗急性脑梗死的临床疗效。 方法 选择急性脑梗死无溶栓禁忌证患者90例，随机分为观察组和对照组，观察组以降纤酶静滴5天后加用STS治疗10天；对照组在降纤酶治疗5天后继续基础治疗10天；观察两组的临床疗效。结果 观察组总有效率93.3%，明显高于对照组86.7%(P<0.01)。结论 降纤酶联合STS治疗急性脑梗死临床疗效较单用降纤酶好。[关键词] 急性脑梗死；降纤酶；丹参酮ⅡA磺酸钠；临床疗效
Effect of defibrase combined with tanshione ⅡA sulfonate injection on acute ceretral infarction
WANG Yuhong,LIU Hong,HAN Pengfei.The second TCM Hospital,Zhanjiang 524013,China
[Abstract] Objective To observe the clinical effect of defibrase combined with sodium tanshinone ⅡA sulfonate injection(STS) in treating acute cerebral infarction. Methods Ninety patients with acute cerebral infarction who without thrombolysis contraindication were randomly divided into treatment group and control group.Those in the treatment group received defibrase combined with STS for 10 days after treating with defibrase for 5 days.The control group received general therapy for 10 days after treating with defibrase for 5 days. Results The effective rate of treatment group was significantly higher than the control group(93.3% vs 86.7% ......
您现在查看是摘要页，全文长 6058 字符。